Broadfin Capital, LLC - Q3 2015 holdings

$3.59 Billion is the total value of Broadfin Capital, LLC's 179 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 29.8% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$436,800,000
+99.9%
4,000,000
+128.6%
24.30%
+107.0%
HZNP BuyHORIZON PHARMA PLC$132,108,000
-21.0%
6,665,391
+38.4%
7.35%
-18.2%
NVRO BuyNEVRO CORP$74,553,000
+230.6%
1,607,085
+283.0%
4.15%
+242.2%
FLML SellFLAMEL TECHNOLOGIES SAsponsored adr$71,674,000
-32.0%
4,394,464
-11.7%
3.99%
-29.6%
XBI BuySPDR SERIES TRUSTput$62,250,000
-13.4%
1,000,000
+250.9%
3.46%
-10.4%
RTRX BuyRETROPHIN INC$52,874,000
-26.3%
2,609,790
+20.7%
2.94%
-23.6%
PGNX  PROGENICS PHARMACEUTICALS IN$51,201,000
-23.3%
8,951,1690.0%2.85%
-20.6%
EBS SellEMERGENT BIOSOLUTIONS INC$46,206,000
-20.3%
1,621,832
-7.9%
2.57%
-17.5%
HRTX SellHERON THERAPEUTICS INC$45,433,000
-39.2%
1,862,001
-22.3%
2.53%
-37.0%
ANGO  ANGIODYNAMICS INC$31,637,000
-19.6%
2,398,5270.0%1.76%
-16.7%
AEGR SellAEGERION PHARMACEUTICALS INC$31,557,000
-41.7%
2,320,366
-18.7%
1.76%
-39.6%
LJPC BuyLA JOLLA PHARMACEUTICAL CO$30,440,000
+63.5%
1,095,373
+44.2%
1.69%
+69.4%
BDSI BuyBIODELIVERY SCIENCES INTL IN$26,377,000
-6.5%
4,744,060
+33.9%
1.47%
-3.2%
REPH BuyRECRO PHARMA INC$24,783,000
+35.7%
2,060,086
+45.7%
1.38%
+40.6%
NVDQ BuyNOVADAQ TECHNOLOGIES INC$19,907,000
+213.8%
1,908,648
+264.3%
1.11%
+224.9%
RXDX  IGNYTA INC$19,812,000
-41.8%
2,256,5460.0%1.10%
-39.8%
DVAX BuyDYNAVAX TECHNOLOGIES CORP$19,379,000
+8.0%
789,710
+3.1%
1.08%
+11.8%
PTX BuyPERNIX THERAPEUTICS HLDGS IN$19,247,000
-35.9%
6,090,829
+20.0%
1.07%
-33.7%
CSII NewCARDIOVASCULAR SYS INC DEL$19,008,0001,200,000
+100.0%
1.06%
ADXS BuyADVAXIS INC$17,768,000
-39.7%
1,736,834
+19.8%
0.99%
-37.6%
IDRA SellIDERA PHARMACEUTICALS INC$17,467,000
-16.9%
5,213,979
-7.9%
0.97%
-13.9%
CORI BuyCORIUM INTL INC$16,850,000
-18.2%
1,802,092
+19.8%
0.94%
-15.3%
MASI NewMASIMO ORD$16,262,000421,728
+100.0%
0.90%
SPNE NewSEASPINE HLDGS CORP$16,200,0001,000,007
+100.0%
0.90%
KMPH SellKEMPHARM INC$15,500,000
+1.9%
799,788
-3.4%
0.86%
+5.5%
SPPI SellSPECTRUM PHARMACEUTICALS$15,050,000
-17.0%
2,516,748
-5.0%
0.84%
-14.1%
EGLTQ BuyEGALET CORP$14,956,000
+138.4%
1,134,750
+161.0%
0.83%
+146.9%
IG  IGI LABS$14,962,000
+3.8%
2,287,7280.0%0.83%
+7.4%
ZGNX NewZOGENIX INC$14,947,0001,107,205
+100.0%
0.83%
AMPH SellAMPHASTAR PHARMACEUTICALS IN$14,928,000
-40.1%
1,276,979
-9.9%
0.83%
-38.0%
ATRS BuyANTARES PHARMA INC$14,408,000
-8.6%
8,475,000
+11.9%
0.80%
-5.3%
RIGL SellRIGEL PHARMACEUTICALS INC$12,659,000
-32.9%
5,125,282
-12.8%
0.70%
-30.6%
CPRX  CATALYST PHARMACEUTICALS INC$12,550,000
-27.4%
4,183,1770.0%0.70%
-24.8%
HTWR NewHEARTWARE INTERNATIONAL$12,537,000239,675
+100.0%
0.70%
HRTX NewHERON THERAPEUTICS INCcall$12,200,000500,000
+100.0%
0.68%
LBIO BuyLION BIOTECHNOLOGIES INC$12,128,000
-27.0%
2,105,519
+16.2%
0.68%
-24.4%
MDGN BuyMEDGENICS INC$12,084,000
+77.0%
1,545,306
+38.7%
0.67%
+83.1%
QLTI  QLT INC$11,825,000
-35.6%
4,445,5270.0%0.66%
-33.3%
TRVN SellTREVENA INC$11,159,000
+26.5%
1,078,132
-23.5%
0.62%
+31.0%
DSCI BuyDERMA SCIENCES INC$11,126,000
-32.9%
2,362,104
+1.9%
0.62%
-30.6%
PETX BuyARATANA THERAPEUTICS INC$11,081,000
-35.3%
1,309,865
+15.7%
0.62%
-32.9%
 PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0$10,816,000
-21.8%
15,500,0000.0%0.60%
-19.1%
RDHL BuyREDHILL BIOPHARMA LTDsponsored ads$10,714,000
+58.3%
829,906
+116.0%
0.60%
+63.7%
SPNC NewSPECTRANETICS CORP$10,614,000900,249
+100.0%
0.59%
MRTX SellMIRATI THERAPEUTICS INC$10,178,000
-10.1%
295,700
-17.8%
0.57%
-6.9%
RTRX NewRETROPHIN INCcall$10,130,000500,000
+100.0%
0.56%
PRTK  PARATEK PHARMACEUTICALS INC$10,075,000
-26.3%
530,2830.0%0.56%
-23.6%
HZNP SellHORIZON PHARMA PLCcall$9,910,000
-74.1%
500,000
-54.5%
0.55%
-73.2%
ARDX SellARDELYX INC$9,492,000
+6.9%
549,290
-15.4%
0.53%
+10.7%
ADHD SellALCOBRA LTD$9,405,000
-9.0%
1,557,106
-1.4%
0.52%
-5.8%
NVRO NewNEVRO CORPcall$9,278,000200,000
+100.0%
0.52%
CYNA SellCYNAPSUS THERAPEUTICS INC$9,052,000
-34.8%
586,117
-33.3%
0.50%
-32.4%
ATRC SellATRICURE INC$8,841,000
-25.8%
403,519
-16.5%
0.49%
-23.1%
RPTP BuyRAPTOR PHARMACEUTICAL CORP$8,549,000
-59.0%
1,412,995
+7.1%
0.48%
-57.5%
AMRN BuyAMARIN CORP PLCspons adr new$8,058,000
-7.1%
4,175,216
+18.4%
0.45%
-3.9%
ADMA  ADMA BIOLOGICS INC$8,061,000
-9.7%
964,1930.0%0.45%
-6.7%
ELOS BuySYNERON MEDICAL LTD$7,545,000
-29.3%
1,055,221
+5.0%
0.42%
-26.8%
GNCA BuyGENOCEA BIOSCIENCES INC$7,167,000
-47.6%
1,046,243
+5.0%
0.40%
-45.7%
ANTH SellANTHERA PHARMACEUTICALS ORD$7,032,000
-40.5%
1,154,674
-15.7%
0.39%
-38.4%
BOTA BuyBIOTA PHARMACEUTIALS INC$6,904,000
+27.7%
3,486,711
+33.5%
0.38%
+32.0%
DPRX SellDIPEXIUM PHARMACEUTICALS INC$6,524,000
+8.0%
465,978
-1.9%
0.36%
+11.7%
CFRX SellCONTRAFECT CORP$6,312,000
+6.0%
1,418,439
-0.0%
0.35%
+9.7%
FATE SellFATE THERAPEUTICS INC$5,938,000
-29.4%
1,113,986
-14.3%
0.33%
-27.0%
TENX  TENAX THERAPEUTICS INC$5,906,000
-18.7%
1,968,6310.0%0.33%
-15.6%
SCYX  SCYNEXIS INC$5,642,000
-17.2%
775,0000.0%0.31%
-14.2%
IRMD SellIRADIMED CORP$5,612,000
-32.2%
230,358
-35.2%
0.31%
-29.9%
BLRX BuyBIOLINERX LTDsponsored adr$5,355,000
-35.1%
3,500,000
+12.9%
0.30%
-32.7%
FLXN SellFLEXION THERAPEUTICS INCsponsored adr$4,803,000
-37.0%
323,188
-7.2%
0.27%
-34.9%
TNXP BuyTONIX PHARMACEUTICALS HLDG C$4,712,000
-30.9%
890,748
+17.1%
0.26%
-28.6%
CBYL  CARBYLAN THERAPEUTICS INC$4,209,000
-50.1%
1,178,9410.0%0.23%
-48.3%
MDWD BuyMEDIWOUND LTD$3,888,000
+359.0%
509,573
+325.1%
0.22%
+369.6%
ARAY SellACCURAY INC$3,746,000
-44.4%
750,000
-25.0%
0.21%
-42.5%
VCYT  VERACYTE INC$3,453,000
-57.9%
736,1960.0%0.19%
-56.5%
EPRSQ  EPIRUS BIOPHARMACEUTICALS IN$3,426,000
-22.6%
775,0000.0%0.19%
-19.7%
CASM  CAS MED SYS INC$3,273,000
-2.3%
2,618,2960.0%0.18%
+1.1%
OSUR  ORASURE TECHNOLOGIES INC$3,044,000
-17.6%
685,5280.0%0.17%
-15.1%
DSCO BuyDISCOVERY LABORATORIES INC N$2,847,000
-46.5%
9,489,166
+21.3%
0.16%
-44.8%
CRDC  CARDICA INC$2,396,000
-45.9%
8,874,9920.0%0.13%
-44.1%
BIOD SellBIODEL INC$2,268,000
-60.5%
5,155,530
-7.6%
0.13%
-59.2%
RXII  RXI PHARMACEUTICALS CORP NEW$2,272,000
-24.3%
6,126,4820.0%0.13%
-21.7%
APHB NewAMPLIPHI BIOSCIENCES CORP$2,180,000552,000
+100.0%
0.12%
CDTX BuyCIDARA THERAPEUTICS INC$2,123,000
+1.0%
166,875
+11.2%
0.12%
+4.4%
BVX  BOVIE MEDICAL CORP$1,847,000
-30.1%
947,4000.0%0.10%
-27.5%
ONTY SellONCOTHYREON$1,623,000
-74.5%
592,200
-65.2%
0.09%
-73.7%
RTTR  RITTER PHARMACEUTICALS INC$1,595,000
-53.9%
778,0000.0%0.09%
-52.2%
ZSAN SellZOSANO PHARMA CORP$1,472,000
-58.1%
371,842
-23.3%
0.08%
-56.6%
MELA BuyMELA SCIENCES INC$1,453,000
+229.5%
1,274,297
+232.2%
0.08%
+237.5%
BDSI SellBIODELIVERY SCIENCES INTL INcall$1,390,000
-76.7%
250,000
-66.7%
0.08%
-76.0%
TTPH NewTETRAPHASE PHARMACEUTICALS$1,194,000160,047
+100.0%
0.07%
PTN NewPALATIN TECHNOLOGIES INC$1,108,0001,368,085
+100.0%
0.06%
TRIV ExitTRIVASCULAR TECHNOLOGIES INC$0-6,032
-100.0%
-0.00%
CAPR ExitCAPRICOR THERAPEUTICS INC$0-118,002
-100.0%
-0.03%
TEAR ExitTEARLAB CORP$0-914,499
-100.0%
-0.10%
UNIS ExitUNILIFE CORP NEW$0-1,150,000
-100.0%
-0.13%
TRNX ExitTORNIER N V$0-100,000
-100.0%
-0.13%
AQXP ExitAQUINOX PHARMACEUTICALS INC$0-531,768
-100.0%
-0.20%
OHRP ExitOHR PHARMACEUTICAL INC$0-1,775,000
-100.0%
-0.24%
PGNX ExitPROGENICS PHARMACEUTICALS INcall$0-600,000
-100.0%
-0.24%
DRRX ExitDURECT CORP$0-2,195,378
-100.0%
-0.28%
COLL ExitCOLLEGIUM PHARMACEUTICAL INC$0-297,200
-100.0%
-0.28%
XOMA ExitXOMA CORP DEL$0-1,500,000
-100.0%
-0.31%
ABMD ExitABIOMED INC$0-100,000
-100.0%
-0.35%
VSTM ExitVERASTEM INC$0-1,050,000
-100.0%
-0.42%
ZGNX ExitZOGENIX INC$0-10,737,645
-100.0%
-0.97%
ALR ExitALERE INC$0-452,423
-100.0%
-1.28%
DEPO ExitDEPOMED INC$0-1,167,442
-100.0%
-1.35%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
  • View 13F-HR/A filed 2015-11-20
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIODELIVERY SCIENCES INTL IN27Q4 20194.8%
HERON THERAPEUTICS INC24Q4 20199.0%
LA JOLLA PHARMACEUTICAL CO24Q4 20197.7%
RECRO PHARMA INC24Q4 20194.1%
ANTARES PHARMA INC24Q3 20193.4%
RETROPHIN INC23Q3 20197.0%
ARATANA THERAPEUTICS INC22Q2 20198.1%
MIRATI THERAPEUTICS INC22Q1 20197.9%
CATALYST PHARM PARTNERS INC22Q3 20196.2%
ANGIODYNAMICS INC21Q3 20186.6%

View Broadfin Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Broadfin Capital, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Eiger BioPharmaceuticals, Inc.Sold outJanuary 04, 202100.0%
LA JOLLA PHARMACEUTICAL COSold outJanuary 04, 202100.0%
STRATA Skin Sciences, Inc.June 23, 20201,529,3924.5%
Teligent, Inc.Sold outFebruary 25, 202000.0%
Neos Therapeutics, Inc.Sold outFebruary 14, 202000.0%
Aclaris Therapeutics, Inc.February 13, 20201,888,0394.6%
Adamas Pharmaceuticals IncSold outFebruary 13, 202000.0%
ADMA BIOLOGICS, INC.Sold outFebruary 13, 202000.0%
AVADEL PHARMACEUTICALS PLCFebruary 13, 20201,029,0122.8%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 13, 202000.0%

View Broadfin Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
42022-03-22
42022-02-15
42022-01-31
42021-11-22
42021-11-15
42021-11-09
42021-08-10
42021-05-13
SC 13G/A2021-01-04
SC 13G/A2021-01-04

View Broadfin Capital, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (3589295000.0 != 1797325000.0)
  • The reported number of holdings is incorrect (179 != 90)
  • The reported has been amended

Export Broadfin Capital, LLC's holdings